<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>gastric cancer progression &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/gastric-cancer-progression/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 14 Oct 2025 14:45:38 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>gastric cancer progression &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Discovering Antralization-Specific Biomarkers in Blood and Gastric Tissue of Patients with Upper GI Symptoms</title>
		<link>https://bioengineer.org/discovering-antralization-specific-biomarkers-in-blood-and-gastric-tissue-of-patients-with-upper-gi-symptoms/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 14 Oct 2025 14:45:34 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Antralization-specific biomarkers]]></category>
		<category><![CDATA[gastric cancer progression]]></category>
		<category><![CDATA[Helicobacter pylori infection]]></category>
		<category><![CDATA[Mucosal molecular remodeling]]></category>
		<category><![CDATA[Upper gastrointestinal symptoms]]></category>
		<guid isPermaLink="false">https://bioengineer.org/discovering-antralization-specific-biomarkers-in-blood-and-gastric-tissue-of-patients-with-upper-gi-symptoms/</guid>

					<description><![CDATA[Antralization, a pivotal and reversible stage in the progression towards gastric cancer, has long evaded precise identification due to the scarcity of reliable biomarkers. This challenge has spurred a groundbreaking prospective study designed to unearth specific biological indicators of antralization, leveraging both peripheral blood analyses and gastric mucosal examinations. Researchers employed a rigorous methodology involving [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">280596</post-id>	</item>
		<item>
		<title>tRF-34-86J8WPMN1E8Y2Q Fuels Gastric Cancer Progression</title>
		<link>https://bioengineer.org/trf-34-86j8wpmn1e8y2q-fuels-gastric-cancer-progression/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 04 Oct 2025 19:10:20 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[cancer biomarkers]]></category>
		<category><![CDATA[gastric cancer progression]]></category>
		<category><![CDATA[LRAT protein interaction]]></category>
		<category><![CDATA[Molecular oncology]]></category>
		<category><![CDATA[tRF-34-86J8WPMN1E8Y2Q]]></category>
		<guid isPermaLink="false">https://bioengineer.org/trf-34-86j8wpmn1e8y2q-fuels-gastric-cancer-progression/</guid>

					<description><![CDATA[Recent research has unveiled a groundbreaking discovery in the field of oncology, focusing on a novel small RNA molecule known as tRF-34-86J8WPMN1E8Y2Q. This molecule has been found to play a significant role in the initiation and progression of gastric cancer, one of the most prevalent and lethal forms of cancer worldwide. The study, conducted by [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">275963</post-id>	</item>
	</channel>
</rss>
